Frequently Asked Questions

What is market size of global CAR T-cell Therapy Market?
The global CAR T-cell therapy market was valued at $206 million in 2019 and is projected to reach $2.84 billion by 2027.
What is the CAGR of the CAR T-cell Therapy Market?
Global Artificial Intelligence Market Is Exhibiting A CAGR Of 13.5% during the Forecast Period.
Which region had major share in the global CAR T-cell Therapy Market?
North America had major share in the global CAR T-cell Therapy Market
What are the key players in the CAR T-cell Therapy Market?
Autolus Therapeutics,Bluebird bio, Inc.,Bristol-Myers Squibb,Caribou Biosciences, Inc.,Cartesian Therapeutics, Inc.,Celgene Corporation,Cellectis,Celyad Oncology,Gilead Sciences, Inc. (Kite Pharma Inc.)u00a0,Intellia Therapeutics,Juno Therapeutics, Inc.,Merck & Co., Inc.,Miltenyi Biotech,Novartis AG,Pfizer, Inc.,Sorrento Therapeutics, Inc.